<?xml version="1.0" encoding="UTF-8"?>
<ref id="B71-vaccines-07-00074">
 <label>71.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Doria-Rose</surname>
    <given-names>N.A.</given-names>
   </name>
   <name>
    <surname>Altae-Tran</surname>
    <given-names>H.R.</given-names>
   </name>
   <name>
    <surname>Roark</surname>
    <given-names>R.S.</given-names>
   </name>
   <name>
    <surname>Schmidt</surname>
    <given-names>S.D.</given-names>
   </name>
   <name>
    <surname>Sutton</surname>
    <given-names>M.S.</given-names>
   </name>
   <name>
    <surname>Louder</surname>
    <given-names>M.K.</given-names>
   </name>
   <name>
    <surname>Chuang</surname>
    <given-names>G.-Y.</given-names>
   </name>
   <name>
    <surname>Bailer</surname>
    <given-names>R.T.</given-names>
   </name>
   <name>
    <surname>Cortez</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Kong</surname>
    <given-names>R.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting</article-title>
  <source>PLoS Pathog.</source>
  <year>2017</year>
  <volume>13</volume>
  <elocation-id>e1006148</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.ppat.1006148</pub-id>
  <pub-id pub-id-type="pmid">28052137</pub-id>
 </element-citation>
</ref>
